Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction

27 Aug 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34461078
DOI: 10.1016/j.ajog.2021.08.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunctionPMID 34461078Read ↗

Low molecular weight heparin for the prevention of severe preeclampsia: where next?Semantic proximity Read ↗

Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets SyndromeSemantic proximity Read ↗

Severe Intrauterine Growth Restriction Pregnancies Have Increased Placental Endoglin LevelsSemantic proximity Read ↗

Inherited Thrombophilia and Pregnancy Complications RevisitedSemantic proximity Read ↗

Transforming Growth Factor-β Expression in Human Placenta and Placental Bed in Third Trimester Normal Pregnancy, Preeclampsia, and Fetal Growth RestrictionSemantic proximity Read ↗

Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm PreeclampsiaSemantic proximity Read ↗

Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women.Semantic proximity Read ↗

Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in PreeclampsiaSemantic proximity Read ↗

Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks’ gestationSemantic proximity Read ↗

Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus controlSemantic proximity Read ↗

The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patientsSemantic proximity Read ↗

Platelet function and response to low-dose aspirin in pregnancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.